For this study, we focused on CYP19A1 SNPs that were predicted to localize within regulatory binding regions, and/or predicted to associate with regulatory proteins involved in pre-mRNA processing, mRNA metabolism and transport, and previously associated with cancer risk and patient outcomes. Here, CYP19A1 is linked to cancer.